Comparison between Curis Lifesciences IPO and NFP Sampoorna Foods IPO.
Curis Lifesciences IPO is a SME Bookbuilding IPO proposed to list at NSE SME while NFP Sampoorna Foods IPO is a SME Bookbuilding proposed to list at NSE SME.
| Curis Lifesciences IPO | NFP Sampoorna Foods IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Finaax Capital Advisors Pvt.Ltd. | 3Dimension Capital Services Ltd. |
| Registrar | MUFG Intime India Pvt.Ltd. | Skyline Financial Services Pvt.Ltd. |
| Market Maker | RS Wealth Management Pvt.Ltd. | Anant Securities |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Curis Lifesciences IPO is up to ₹26.14 Cr whereas the issue size of the NFP Sampoorna Foods IPO is up to ₹23.30 Cr. The final issue price of Curis Lifesciences IPO is ₹128.00 per share and of NFP Sampoorna Foods IPO is ₹55.00 per share.
| Curis Lifesciences IPO | NFP Sampoorna Foods IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹120.00 per share | ₹52.00 per share |
| Issue Price (Upper) | ₹128.00 per share | ₹55.00 per share |
| Issue Price (Final) | ₹128.00 per share | ₹55.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 1000 shares | 2000 shares |
| Fresh Issue Size | 20,42,000 shares | 42,36,000 shares |
| Fresh Issue Size (Amount) | up to ₹26.14 Cr | up to ₹23.30 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 20,42,000 shares | 42,36,000 shares |
| Issue Size Total (Amount) | up to ₹26.14 Cr | up to ₹23.30 Cr |
Curis Lifesciences IPO opens on Nov 07, 2025, while NFP Sampoorna Foods IPO opens on May 18, 2026. The closing date of Curis Lifesciences IPO and NFP Sampoorna Foods IPO is Nov 11, 2025, and May 20, 2026, respectively.
| Curis Lifesciences IPO | NFP Sampoorna Foods IPO | |
|---|---|---|
| Anchor Bid Date | Nov 06, 2025 | |
| Issue Open | Nov 07, 2025 | May 18, 2026 |
| Issue Close | Nov 11, 2025 | May 20, 2026 |
| Basis Of Allotment (Tentative) | Nov 12, 2025 | May 21, 2026 |
| Initiation of Refunds (Tentative) | Nov 13, 2025 | May 22, 2026 |
| Credit of Share (Tentative) | Nov 13, 2025 | May 22, 2026 |
| Listing date (Tentative) | Nov 14, 2025 | May 25, 2026 |
| Anchor Lockin End date 1 | Dec 11, 2025 | |
| Anchor Lockin End date 2 | Feb 09, 2026 |
Curis Lifesciences IPO P/E ratio is 12.44, as compared to NFP Sampoorna Foods IPO P/E ratio of 16.81.
| Curis Lifesciences IPO | NFP Sampoorna Foods IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated Consolidated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 92.68 | 99.99 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 68.03 | 64.69 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 12.44 | 16.81 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹103.48 Cr. | ₹69.49 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 55.25 | 34.82 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 27.83 | 40.90 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.96 | 1.26 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹10.29 | ₹3.27 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 37.62 | 29.65 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Curis Lifesciences IPO Retail Individual Investors (RII) are offered 7,16,000 shares while in NFP Sampoorna Foods IPO retail investors are offered 7,16,000 shares. Qualified Institutional Buyers (QIB) are offered 4,08,000 shares in Curis Lifesciences IPO and 42,000 shares in NFP Sampoorna Foods IPO.
| Curis Lifesciences IPO | NFP Sampoorna Foods IPO | |
|---|---|---|
| Anchor Investor Reservation | 6,09,000 shares | 0 shares |
| Market Maker Reservation | 1,08,000 shares | 2,24,000 shares |
| QIB | 4,08,000 shares | 42,000 shares |
| NII | 3,09,000 shares | 20,94,000 shares |
| RII | 7,16,000 shares | 21,00,000 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 20,42,000 shares | 42,36,000 shares |
Curis Lifesciences IPO subscribed 52.21x in total, whereas NFP Sampoorna Foods IPO subscribed 1.57x.
| Curis Lifesciences IPO | NFP Sampoorna Foods IPO | |
|---|---|---|
| QIB (times) | 96.41x | 1.00x |
| NII (times) | 115.09x | 0.34x |
| Big NII (times) | 142.05x | 0.11x |
| Small NII (times) | 60.38x | 0.80x |
| RII (times) | 44.28x | 2.80x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 52.21x | 1.57x |
